The securities of Botanix Pharmaceuticals Ltd (formerly Bone Medical Ltd) (the “Company”) were suspended from Official Quotation on 14 June 2016.
The securities of the Company will be reinstated to Official Quotation from the commencement of trading on Friday 15 July 2016 following the Company’s compliance with Listing Rule 11.1.3 and Chapter 1 and 2 of the ASX Listing Rules.
Quoted securities: |
252,338,128 fully paid ordinary shares |
ASX code: |
BOT |
Time: |
10:00 AM AEST (08:00 AM WST) |
Date: |
Friday 15 July 2016 |
ASX Trade abbreviation: |
BOTANIX |
ISIN: |
AU000000BOT2 |
Home branch: |
Perth |
Industry classification: |
TBA |
Registered office: |
Ground Floor, 16 Ord Street West Perth WA 6005 |
Company secretary: |
Brett Tucker |
Share registry: |
Automic Registry Services Suite 1A, Level 1, 7 Ventnor Avenue West Perth WA 6005 |
Balance date: |
30 June |
CHESS: |
Participating. The Company will also operate an issuer-sponsored sub-register. |
Place of incorporation: |
Western Australia. |
Dividend policy: |
See section 5.4 (page 56) of the Company’s Prospectus dated 13 May 2016. |
Activities: |
Pharmaceuticals. |
Restricted securities: |
156,476,642 fully paid ordinary shares, classified by ASX as restricted securities and to be held in escrow for a period of 24 months from reinstatement to official quotation. 13,000,000 unquoted options exercisable at $0.03 expiring 30 June 2019, classified by ASX as restricted securities and to be held in escrow for a period of 24 months from reinstatement to official quotation. |
Securities not quoted: |
7,740,888 unquoted options exercisable at $0.133 expiring 31 December 2016. 1,799,968 unquoted options exercisable at $0.10 expiring 31 December 2016. |
For further details, please refer to the Company’s prospectus.
Ben Tippett, Adviser, Listings Compliance (Perth)
Ben Tippett
+61 (08) 9224 0000
info@asx.com.au